Cuban Heberferon Drug to Treat Several Malignant Tumors
Published 22 February 2022 (3 hours 14 minutes ago)
The effectiveness of Cuban drug Heberferon for treating several malignant tumors is now being investigated by specialists at the Center for Genetic Engineering and Biotechnology (CIGB).
Doctor in Biological Sciences Iraldo Bello, the project leader, noted that the product, which was initially designed to treat skin cancer, has the potential to be used as a therapeutic alternative in brain diseases and renal carcinomas.
The doctor stated that patients' responses in grades three and four are still being evaluated in the latter case. However, evidence shows that the drug contributes to prolonging the patient's survival.
Clinical trials are being studied, and so are the results of the drug in people with advanced breast, head and neck cancer.
More:
https://www.telesurenglish.net/news/Cuban-Heberferon-Drug-to-Treat-Several-Malignant-Tumors-20220222-0020.html
